Literature DB >> 3400268

Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavage.

R W Teel1, R M Martin.   

Abstract

1. The absorption, distribution and elimination of 3H-ellagic acid, a putative antimutagen and anticarcinogen, was studied in male Swiss-Webster mice following oral administration. 2. Levels of 3H-ellagic acid were highest in blood 30 min after administration, in urine and bile 120 min post-administration, and in liver, lung and kidney 15 min after administration [corrected]. 3. Free ellagic acid and its conjugates were present in urine, bile and blood. H.p.l.c. analysis of the organic solvent extracts of urine, bile and blood indicated the presence of four metabolites in urine, two in blood and one in bile. 4. Sulphate ester, glucuronide and glutathione conjugates of ellagic acid were present in urine, bile and blood. H.p.l.c. analysis of organic solvent extracts after aryl sulphatase or beta-glucuronidase treatment showed that ellagic acid was the major component present. 5. Absorption of 3H-ellagic acid occurred mostly within two hours after oral administration. Levels in blood, bile and tissues were low and almost all of the absorbed dose was excreted in urine. 6. More than 53% of the orally administered 3H-ellagic acid remained in the gastrointestinal tract at 24 h. Approximately 19% was excreted in faeces and 22% in urine at 24 h. 7. Of the 24 h faecal radioactivity 93% was extractable into organic solvents and more than 80% of this fraction was free ellagic acid. Only one metabolite was found in faeces.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3400268     DOI: 10.3109/00498258809041676

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  In vitro and in vivo properties of ellagic acid in malaria treatment.

Authors:  Patrice Njomnang Soh; Benoît Witkowski; David Olagnier; Marie-Laure Nicolau; Maria-Concepcion Garcia-Alvarez; Antoine Berry; Françoise Benoit-Vical
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

2.  The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.

Authors:  Begoña Cerdá; Juan Carlos Espín; Soledad Parra; Pedro Martínez; Francisco A Tomás-Barberán
Journal:  Eur J Nutr       Date:  2004-01-06       Impact factor: 5.614

3.  Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines.

Authors:  Gamal Allam; Emad A Mahdi; Abdullah M Alzahrani; Abdelaziz S Abuelsaad
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

4.  Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation.

Authors:  Hongkai Wang; Yingxia Zhang; Zhongjing Tian; Jing Ma; Meiling Kang; Chengshi Ding; Dongfeng Ming
Journal:  Molecules       Date:  2017-12-08       Impact factor: 4.411

5.  Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice.

Authors:  Daniely Cornélio Favarin; Maxelle Martins Teixeira; Ednéia Lemos de Andrade; Claudiney de Freitas Alves; Javier Emilio Lazo Chica; Carlos Artério Sorgi; Lúcia Helena Faccioli; Alexandre Paula Rogerio
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

6.  Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages.

Authors:  Abhishek Dubey; Dae Won Park; Jung Eun Kwon; Yong Joon Jeong; Taegeun Kim; Inhye Kim; Se Chan Kang; Ki-Whan Chi
Journal:  Int J Nanomedicine       Date:  2015-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.